Abstract
AIM: To evaluate post-marketing label changes in dosing information of biologicals. METHODS: Biologicals authorised between 2007 and 2014 by the European Medicines Agency (EMA) were included and followed up from marketing authorisation until 31 December 2016 or date of withdrawal of the marketing authorisation. The primary outcome of the study
... read more